Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

SES AI's innovative business model, combining subscription and product revenue, is expected to yield high margins and ...

Understanding these risks is the first step toward creating a cleaner, safer future. Researchers make alarming new discovery ...

Freyr Battery (NYSE:FREY) has informed officials in a suburban Atlanta county that it won’t proceed with a $2.6B plant, the Newnan Times Herald reported Thursday. According to the report, the ...

One leading theory on the origins of life on Earth proposes that simple chemical molecules gradually became more complex, ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

Olive oil bioactives, including MUFAs, polyphenols, and triterpenoids, modulate gene expression linked to insulin sensitivity ...

By age 75, a noteworthy 50% of men develop an inguinal (groin) hernia - a bulge that results from soft tissue pushing through a weak spot in the abdominal muscles.

By age 75, a noteworthy 50% of men develop an inguinal (groin) hernia—a bulge that results from soft tissue pushing through a ...

Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

J&J, AstraZeneca, Novo Nordisk and Roche are among the companies that might take a hit from the soon-to-be-enacted fees, ...